Blog
RSS FeedPosted by Michael Wonder on 23 Jul 2020
PBAC statement of endorsement for transparency measures and standardised redactions to public summary documents
23 July 2020 - The PBAC has made a statement outlining its support for measures to improve the transparency of ...
Posted by Michael Wonder on 21 Jul 2020
ICER publishes evidence report on obeticholic acid for the treatment of non-alcoholic steatohepatitis
21 July 2020 - Given the FDA’s recent decision to not grant accelerated approval for the treatment, ICER has canceled its ...
Posted by Michael Wonder on 21 Jul 2020
TGA publishes AusPAR for Vemlidy
21 July 2020 - AusPAR published within days of its provisional registration; why do other take years? ...
Posted by Michael Wonder on 17 Jul 2020
Public Summary Documents - March 2020 meeting
17 July 2020 - The Public Summary Documents (first time rejections and deferrals) from the March 2020 PBAC meeting are now ...
Posted by Michael Wonder on 03 Jul 2020
Public Summary Documents - March 2020 PBAC meeting
3 July 2020 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2020 PBAC ...
Posted by Michael Wonder on 25 May 2020
Final report for the post-market review of pulmonary arterial hypertension medicines
25 May 2020 - The final report and outcomes of the post-market review of pulmonary arterial hypertension medicines are now publicly ...
Posted by Michael Wonder on 06 May 2020
Half yearly performance snapshot: July to December 2019
6 May 2020 - The TGA prepares an annual TGA Business Plan, which identifies the priority activities being undertaken over the ...
Posted by Michael Wonder on 05 May 2020
EMA publishes minutes of joint meeting with EUnetHTA - November 2019
5 May 2020 - This was the 18th meeting between the EMA and representatives from the EUnetHTA and attended by the ...
Posted by Michael Wonder on 30 Apr 2020
Procedure Guidance for standardised redactions to PBAC Public Summary Documents
30 April 2020 - The PBAC has indicated its preference for greater transparency to be introduced in PSDs through a ...
Posted by Michael Wonder on 09 Apr 2020
Public Summary Documents - December 2019 PBAC meeting
9 April 2020 - The Public Summary Documents relating to the December 2019 PBAC meeting are now available. ...
Posted by Michael Wonder on 26 Mar 2020
Public Summary Documents - November 2019 PBAC meeting (supplement)
26 March 2020 - Additional insights from the second round of public summary documents (first time rejections and deferrals). ...
Posted by Michael Wonder on 25 Mar 2020
Public Summary Documents - November 2019 PBAC meeting
25 March 2020 - Insights from the second round of public summary documents (first time rejections and deferrals). ...
Posted by Michael Wonder on 20 Mar 2020
PBAC Public Summary Documents - November 2019 meeting (first time rejections and deferrals)
20 March 2020 - The public summary documents (first rejections and deferrals) from the November 2019 PBAC meeting are now available. ...
Posted by Michael Wonder on 19 Mar 2020
ICER releases draft evidence report on obeticholic acid for non-alcoholic steatohepatitis
19 March 2020 - Public comment period on preliminary draft now open until 24 June 2020; requests to make oral comment ...
Posted by Michael Wonder on 13 Mar 2020
ICER releases evidence report on treatments for sickle cell disease
12 March 2020 - Three new treatments use different mechanisms to improve patient outcomes, offering important options for patients. ...